Economy

Spot Check on Stock With Abnormal Activity Aerie Pharmaceuticals, Inc. (NASDAQ:AERI)

Spot Check on Stock With Abnormal Activity Aerie Pharmaceuticals, Inc. (NASDAQ:AERI)”

Federated Investors Inc. PA now owns 4,447 shares of the company's stock worth $168,000 after buying an additional 2,090 shares during the last quarter. 697,636 shares of the company traded hands. It has underperformed by 35.98% the S&P500. Including today's unusual volume, Aerie Pharmaceuticals, Inc.'s stock is performing at 54.82% on the year.

Aerie Pharmaceuticals Company Profile Aerie Pharmaceuticals, Inc is a clinical-stage pharmaceutical company.

Short traders are feeling a little more bearish on shares of the company as evidenced by the rise in short interest. It has outperformed by 163.50% the S&P500.The move comes after 9 months negative chart setup for the $1.98B company.

Among 13 analysts covering Aerie Pharmaceuticals (NASDAQ:AERI), 13 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Aerie Pharmaceuticals had 32 analyst reports since August 7, 2015 according to SRatingsIntel. On Thursday, July 20 the stock rating was maintained by H.C. Wainwright with "Buy". The company was maintained on Thursday, September 17 by Stifel Nicolaus. Cantor Fitzgerald maintained the stock with "Buy" rating in Thursday, July 20 report. RBC Capital Markets maintained the shares of AERI in report on Friday, October 28 with "Outperform" rating. Principal Financial Group bought a fresh stake in Aerie Pharmaceuticals in the 2nd period worth at $427,000. The company was maintained on Friday, September 15 by Needham.

Aerie Pharmaceuticals (NASDAQ:AERI) last posted its quarterly earnings data on Tuesday, August 1st. The Business's product candidates include Rhopressa (netarsudil ophthalmic solution) 0.02% (Rhopressa), and Roclatan (netarsudil/latanoprost ophthalmic solution) 0.02%/0.005% (Roclatan). Below is a list of Aerie Pharmaceuticals Inc (NASDAQ:AERI) latest ratings and price target changes. The company has market cap of $1.98 billion.

Cabot holds 15.54% of its portfolio in Cabot Corp for 388,771 shares.

Since May 9, 2017, it had 1 insider purchase, and 1 sale for $1.08 million activity. BlueCrest Capital Management Ltd acquired a new position in Aerie Pharmaceuticals in the 1st quarter valued at approximately $202,000.

Investors sentiment decreased to 1.13 in Q4 2016. Its down 1.36, from 2.49 in 2016Q3.

As of the end of the quarter Venbio Select Advisor LLC had sold 194,158 shares trimming its holdings by 45.7%. 15 funds opened positions while 56 raised stakes. AXA held about 0.57% of Aerie Pharmaceuticals during the latest fiscal quarter. Fiduciary Trust Co owns 1.19 million shares or 1.96% of their U.S. portfolio.

05/25/2017 - Aerie Pharmaceuticals, Inc. had its "outperform" rating reiterated by analysts at Cowen. The stock of Aerie Pharmaceuticals Inc (NASDAQ:AERI) earned "Strong Buy" rating by Raymond James on Wednesday, September 14. Envestnet Asset holds 0% or 414 shares. Thrivent Financial For Lutherans owns 109,130 shares. Dekabank Deutsche Girozentrale has invested 0.01% in Aerie Pharmaceuticals Inc (NASDAQ:AERI). Endurant Cap Mgmt Limited Partnership invested in 0.98% or 62,630 shares. Geduld E E holds 0.13% of its portfolio in Aerie Pharmaceuticals Inc (NASDAQ:AERI) for 6,000 shares. Bnp Paribas Arbitrage owns 463 shares.

About 64,596 shares traded.

Analysts await Aerie Pharmaceuticals Inc (NASDAQ:AERI) to report earnings on November, 1. They expect $0.92 earnings per share, down 8.00% or $0.08 from last year's $1 per share.

Many other big clients also quite recently purchased and unloaded stocks of the shares. Iguana Healthcare Management, LLC expanded its stake by buying 10,000 shares an increase of 11.8% from 03/31/2017 to 06/30/2017. Short shares increased 809,364 over that period. CBT's profit will be $57.24M for 14.63 P/E if the $0.92 EPS becomes a reality.

The company reported ($0.76) earnings per share for the quarter, missing analysts' consensus estimates of ($0.74) by $0.02.



Like this

loading...
loading...

Latest


21 September 2017
Jr. Currens Sells 600 Shares of Duke Energy Corporation (DUK) Stock
BidaskClub upgraded Duke Energy Corporation from a "sell" rating to a "hold" rating in a report on Monday, July 24th. It also reduced Pioneer Natural Resources Company (NYSE:PXD) stake by 17,742 shares and now owns 54,012 shares.

21 September 2017
Pacific Grove Capital LP Cuts Stake in Mondelez International, Inc. (NASDAQ:MDLZ)
For MDLZ , the company now has 1.4 billion of cash on the books, which is offset by 5.56 billion in current liabilities. Several other institutional investors and hedge funds also recently added to or reduced their stakes in the business.

21 September 2017
Is Under Armour (NYSE:UAA) In Trouble? Wells Fargo Issues Downgrade
Finally, NEXT Financial Group Inc purchased a new position in Under Armour in the second quarter worth about $204,000. Mn Services Vermogensbeheer B.V. purchased a new position in Under Armour in the second quarter worth about $651,000.

21 September 2017
Hurricane Maria Leaves Dominica Devastated, Approaching Puerto Rico
Maria will move near the Turks and Caicos Islands and southeastern Bahamas Thursday night and Friday , the hurricane center said . Around 40 percent of the island - 80,000 homes - were without power and flooding was accounted for in a few groups.

21 September 2017
South Korea says Trump's North Korea rhetoric shows resolve
Trump called on member states to reject "business as usual" and not be "beholden to ways of the past which were not working". Now, in an interview with 21 News, Ohio Senator Sherrod Brown says the rhetoric used by Pres.

21 September 2017
No. 6 Oklahoma State, No. 16 TCU set for Big 12 battle
Receiver James Washington leads active FBS players in receiving yards (3,290), touchdowns (29) and yards per catch (19.9). Senior wide receiver Ty Slanina, who missed the last two games with an undisclosed injury, is expected to return.

21 September 2017
Apple Inc. (AAPL) Shares Bought by Northstar Asset Management LLC
Drexel Hamilton reissued a buy rating and set a $208.00 price target on shares of Apple in a report on Wednesday, September 13th. Ten equities research analysts have rated the stock with a hold rating and forty-four have issued a buy rating to the stock.

20 September 2017
Redskins RB Rob Kelley suffered rib cartilage injury, remains day-to-day
But there is some good news regarding Kelley, and he's now considered day-to-day with a rib cartilage injury. Kelley had 12 carries for 78 yards before leaving, with rookie Samaje Perine replacing him.

20 September 2017
This Weeks Target Prices For ProLogis, Inc. (NYSE:PLD)
Finally, BidaskClub upgraded shares of Prologis from a "buy" rating to a "strong-buy" rating in a report on Friday, August 18th. The company reported $0.63 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $0.63 by $0.00.

20 September 2017
Progressive Corporation (The) (NYSE:PGR) Trading Volume Significantly Higher
The Progressive Corporation (NYSE:PGR) share price increased in the last trading session with a previous 52-week high of $49.01. On September 18 Credit Suisse left the company rating at "Underperform" and moved up the price target from $30.00 to $42.00.